Researchers have identified key differences between HSV-1 and HSV-2 and have developed monoclonal antibodies that could treat neonatal infections.
List view / Grid view
Dartmouth's Geisel School of Medicine
The study’s findings have important implications for better understanding the neurological basis for ASD and developing effective therapies for patients.
A new study shows that the VISTA molecule stops the immune system responding to self-antigens, including those presented by cancer cells, so an anti-VISTA antibody could be a possible therapy.